Similar Posts
Tilaknagar Industries Falls 5% on Rs 2,296 Crore Preferential Issue for Imperial Blue Buy
July 30, 2025July 30, 2025 Shares of Tilaknagar Industries Ltd fell 5% after hitting a day’s high of Rs 517.25 on 30th July, after the company announced that its Board had approved a preferential issue of securities — comprising equity shares and warrants — worth around Rs 2,296 crore….
Japan’s Export Growth Slows in April as US Tariffs Hit Trade – Equitypandit
May 21, 2025May 21, 2025 Japan’s exports rose 2% in April from a year earlier, below the expected 2.5% rise, while imports fell 2.2%. The yen was 2.6% stronger at 147.7 per dollar, weighing on the value of exports and imports. After two months of…
ICICI Bank Q4 Results: Net profit surges 18% YoY, NII advances 11%
ICICI Bank, India’s second largest private lender, today declared an 18% year-on-year (YoY) surge in its Q4FY25 PAT, which stood at Rs 12,630 crore at the end of the quarter, while its net interest income (NII) rose 11% YoY to Rs 21,193 crore in the same time period. Meanwhile, for the full financial year 2025,…
IndusInd Bank Q1 Preview: Profit seen falling up to 91% YoY amid derivative loss overhang; 7 things to watch out for
IndusInd Bank will announce its Q1 earnings on Monday, July 28, where the private lender is expected to report a sharp decline in its year-on-year net profit driven by elevated provisioning, MFI stress, and weak loan/deposit growth. Seen as a recovery quarter after losses in the derivatives segment in the previous quarter, the Street will…
Revive Therapeutics Provides Update on FDA Type C Meeting for Clinical Study of Bucillamine to Treat Long COVID – Bio Tech Winners
June 12, 2024 by Leave a Comment Last Updated on June 12, 2024 by [#item_full_content] Like this: Like Loading… Related Filed Under: biotech news, News Reader Interactions This site uses Akismet to reduce spam. Learn how your comment data is processed. Source link
